|
Q2 FY2026
As of Jun 28, 2026
|
Q1 FY2026
As of Mar 29, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 28, 2025
|
Q2 FY2025
As of Jun 29, 2025
|
Q1 FY2025
As of Mar 30, 2025
|
Q4 FY2024
As of Dec 29, 2024
|
Q3 FY2024
As of Sep 29, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Oct 1, 2023
|
Q2 FY2023
As of Jul 2, 2023
|
Q1 FY2023
As of Apr 2, 2023
|
Q4 FY2022
As of Jan 1, 2023
|
Q3 FY2022
As of Oct 2, 2022
|
Q2 FY2022
As of Jul 3, 2022
|
Q1 FY2022
As of Apr 3, 2022
|
Q4 FY2021
As of Jan 2, 2022
|
Q3 FY2021
As of Oct 3, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $16 and $18, as of October 1, 2023 and January 1, 2023, respectively | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $0.1M as of June 28, 2026 and $0 as of December 28, 2025 | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Note receivable, current | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets of business held for disposal, net | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Capitalized internal-use software, net | ||||||||||||||||||||
| Right of use assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Non-marketable equity investment | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Inventories, non-current, net | ||||||||||||||||||||
| Financing Receivable, after Allowance for Credit Loss, Noncurrent | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Revolving line of credit | ||||||||||||||||||||
| Trade payables | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Note payable, current | ||||||||||||||||||||
| Lease liabilities, current | ||||||||||||||||||||
| Liabilities of business held for sale | ||||||||||||||||||||
| Liabilities of business held for disposal | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Lease liabilities, non-current | ||||||||||||||||||||
| Notes payable, non-current | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value; 200,000 authorized; 18,316 and 17,290 shares issued and outstanding as of June 28, 2026 and December 28, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
